实性为主与纯实性IA期低代谢肺腺癌淋巴结转移比较
该回顾性研究纳入192例c-IA2至IA3期实性为主低代谢(SUVmax≤2.7)肺腺癌患者,比较部分实性与纯实性肿瘤的淋巴结转移及复发。纯实性组病理淋巴结转移比例显著高于部分实性组(8.6% vs 0%,P<.01),5年累积复发率亦更高(12.1% vs 0%,P<.01)。结论提示纯实性低代谢c-IA2至IA3肺腺癌仍需行淋巴结清扫。
要点
- 纯实性低代谢c-IA2至IA3肺腺癌病理淋巴结转移达8.6%,部分实性组为0%。
- 纯实性组5年累积复发率12.1%,部分实性组为0%。
- 纯实性外观者即使低代谢也应行淋巴结清扫。
核心结论
- 纯实性低代谢c-IA2至IA3肺腺癌的病理淋巴结转移和复发风险显著高于部分实性肿瘤,淋巴结清扫仍有必要。
研究设计与样本
- 回顾性研究,纳入2008至2017年192例c-IA2至IA3期实性为主低代谢(SUVmax≤2.7)肺腺癌解剖性肺切除患者。
- 按实性成分占比分为部分实性(0.5<实性占比<1.0)与纯实性(实性占比=1.0)两组。
- 采用Gray模型评估GGO的预后意义,以无复发性死亡为竞争风险。
主要发现
- 中位随访108.3个月,部分实性134例(70%),纯实性58例(30%)。
- 163例(85%)为c-IA2期,156例(81%)行肺叶切除,144例(75%)行纵隔淋巴结清扫。
- 病理淋巴结转移共5例(8.6%),均为纯实性肿瘤,其中N1转移2例、N2转移3例。
- 纯实性组病理淋巴结转移比例显著高于部分实性组(8.6% vs 0%;P<.01)。
- 部分实性组无术后疾病进展;纯实性组5年累积复发率更高(12.1% vs 0%;P<.01)。
关键数值与推荐
- 病理淋巴结转移比例:纯实性组8.6% vs 部分实性组0%(P<.01)。
- 5年累积复发率:纯实性组12.1% vs 部分实性组0%(P<.01)。
- 纯实性组5例淋巴结转移中N1为2例、N2为3例。
临床怎么用
- 对c-IA2至IA3期纯实性低代谢肺腺癌,即使SUVmax≤2.7,仍应行淋巴结清扫。
- 部分实性低代谢肿瘤淋巴结转移与复发风险低,可据此个体化评估淋巴结处理策略。
局限性
- 为单中心回顾性研究,样本量192例,纯实性组仅58例。
- 病理淋巴结转移事件仅5例,相关比较的统计效能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study investigated the oncologic role of the ground-glass opacity (GGO) component in lymph node dissection for clinical (c)-stage IA solid-predominant hypometabolic lung adenocarcinoma with a low maximum standardized uptake value (SUVmax). METHODS: The study retrospectively reviewed 192 patients who underwent anatomic lung resection for c-stage IA2 to IA3 solid-predominant lung adenocarcinomas with hypometabolic activity (SUVmax ≤2.7) between 2008 and 2017. Patients were classified as having part-solid (0.5< consolidation-to-tumor ratio < 1.0) or pure-solid (consolidation-to-tumor ratio = 1.0) tumors. The prognostic significance of the GGO was evaluated using Gray's model, with a competing risk of death without recurrence. RESULTS: The median follow-up duration was 108.3 months. Overall, 134 (70%) and 58 (30%) patients had part-solid and pure-solid tumors, respectively. Of these, 163 (85%) patients received a diagnosis of c-stage IA2 disease, and 156 (81%) underwent lobectomy. Mediastinal lymph node dissection was performed in 144 (75%) patients. Pathologic nodal metastases were observed in 5 cases (8.6%), which were found to be pure-solid tumors. Among the 5 cases, N1 metastasis was detected in 2, and N2 metastasis was detected in 3. The proportion of pathologic nodal metastases (8.6% vs 0%; P < .01) was significantly higher in the pure-solid group than in the part-solid tumor group. None of the patients with part-solid tumors showed postoperative disease progression. The 5-year cumulative incidence of recurrence was higher in the pure-solid group than in the part-solid group (12.1% vs 0%; P < .01). CONCLUSIONS: Lymph node dissection is warranted in c-stage IA2 to IA3 lung adenocarcinoma with a pure-solid appearance, even with hypometabolic activity.
引用
- Watanabe Y, Uchida S, Hattori A, et al. A Comparative Analysis of Nodal Spread in Solid-Predominant vs Pure-Solid Stage IA Hypometabolic Lung Adenocarcinoma. Ann Thorac Surg. 2025. PMID: 41046010. doi:10.1016/j.athoracsur.2025.08.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。